Genetic basis of Hirschsprung disease: Implications in clinical practice

Molecular Genetics and Metabolism

Volumn 80, Issue 1-2, 2003, Pages 66-73

  Gariepy, Cheryl E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARDET BIEDL SYNDROME; CARTILAGE HYPOPLASIA; CHROMOSOME ABERRATION; CLINICAL PRACTICE; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; DOWN SYNDROME; FAMILY HISTORY; FECES INCONTINENCE; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC TRAIT; HIRSCHSPRUNG DISEASE; HOMOZYGOTE; HUMAN; HYPOPLASIA; LONG TERM CARE; MCKUSICK KAUFMAN SYNDROME; MOLECULAR GENETICS; MUSCULAR DYSTROPHY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PULL THROUGH OPERATION; SEX RATIO; SHORT SURVEY; SMITH LEMLI OPITZ SYNDROME; TREATMENT PLANNING; TRISOMY 21; WAARDENBURG SYNDROME;

EID: 0142026110     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.08.007     Document Type: Short Survey

References (86)

1. Russell M.B., Russell C.A., Niebuhr E. An epidemiological study of Hirschsprung's disease and additional anomalies. Acta. Pediatr. 83:1994;68-71.
2. Descos B., Lachaux A., Louis D., Chopard P., Gilly J., Chayvialle J.A., Hermier M. Extended intestinal aganglionosis in siblings. J. Pediatr. Gastroenterol. Nur. 3:1984;641-643.
3. Ward J., Sierra I.A., D'Croz E. Cat eye syndrome associated with aganglionosis of the small and large intestine. J. Med. Genet. 26:1989;647-648.
4. Inoue K., Shimotake T., Iwai N. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement. Am. J. Med. Genet. 93:2000;278-284.
5. Le Douarin N.M., Teillet M.A. The migration of neural crest cells to the wall of the digestive tract in avian embryo. J. Embryol. Exper. Morphol. 30:1973;31-48.
6. Passarge E. The genetics of Hirschsprung's disease. Evidence for heterogeneous etiology and a study of sixty-three families. N. Engl. J. Med. 276:1967;138-143.
7. Spouge D., Baird P.A. Hirschsprung disease in a large birth cohort. Teratology. 32:1985;171-177.
8. Goldberg E.L. An epidemiological study of Hirschsprung's disease. Int. J. Epidemiol. 13:1984;479-485.
9. Kleinhaus S., Boley S.J., Sheran M., Sieber W.K. Hirschsprung's disease - a survey of the members of the Surgical Section of the American Academy of Pediatrics. J. Pediatr. Surg. 14:1979;588-597.
10. Badner J.A., Sieber W.K., Garver K.L., Chakravarti A. A genetic study of Hirschsprung disease. Am. J. Hum. Genet. 46:1990;568-580.
11. Ryan E.T., Ecker J.L., Christakis N.A., Folkman J. Hirschsprung's disease: associated abnormalities and demography. J. Pediatr. Surg. 27:1992;76-81.
12. Brown R.A., Cywes S. Disorders and congenital malformations associated with Hirschsprung's disease. Hirschsprung's Disease and Allied Disorders. 2000;137-145 Harwood Academic Publishers, Amsterdam.
13. Ludman L., Spitz L., Tsuji H., Pierro A. Hirschsprung's disease: functional and psychological follow up comparing total colonic and rectosigmoid aganglionosis. Arch. Dis. Child. 86:2002;348-351.
14. Tsuji H., Spitz L., Kiely E.M., Drake D.P., Pierro A. Management and long-term follow-up of infants with total colonic aganglionosis. J. Pediatr. Surg. 34:1999;158-161. (discussion 162).
15. Yanchar N.L., Soucy P. Long-term outcome after Hirschsprung's disease: patients' perspectives. J. Pediatr. Surg. 34:1999;1152-1160.
16. Kobayashi H., Hirakawa H., Surana R., O'Briain D.S., Puri P. Intestinal neuronal dysplasia is a possible cause of persistent bowel symptoms after pull-through operation for Hirschsprung's disease. J. Pediatr. Surg. 30:1995;253-257. (discussions 257-259).
17. Fadda B., Maier W.A., Meier-Ruge W., Scharli A., Daum R. Neuronal intestinal dysplasia. Critical 10-years' analysis of clinical and biopsy diagnosis. Zeitsch. Kinderchirur. 38:1983;305-311.
18. Koletzko S., Jesch I., Faus-Kebetaler T., Briner J., Meier-Ruge W., Muntefering H., Coerdt W., Wessel L., Keller K.M., Nutzenadel W., Schmittenbecher P., Holschneider A.M., Sacher P. Rectal biopsy for diagnosis of intestinal neuronal dysplasia in children: a prospetive multicentre study on interobserver variation and clinical outcome. Gut. 44:1999;853-861.
19. Gath R., Goessling A., Keller K.M., Koletzko S., Coerdt W., Muntefering H., Wirth S., Hofstra R.M., Mulligan L., Eng C., von Deimling A. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease. Gut. 48:2001;671-675.
20. Rolle U., Piotrowska A.P., Nemeth L., Puri P. Altered distribution of interstitial cells of Cajal in Hirschsprung disease. Arch. Pathol. Laborat. Med. 126:2002;928-933.
21. Fishbein T.M., Gondolesi G.E., Kaufman S.S. Intestinal transplantation for gut failure. Gastroenterology. 124:2003;1615-1628.
22. Garcia-Castro M., Bronner-Fraser M. Induction and differentiation of the neural crest. Curr. Opin. Cell Biol. 11:1999;695-698.
23. Le Dourarin N.M., Kalcheim C. The Neural Crest. 1999;Cambridge University Press, New York.
24. Kapur R.P., Hoyle G.W., Mercer E.H., Brinster R.L., Palmiter R.D. Some neuronal cell populations express human dopamine beta-hydroxylase-lacZ transgenes transiently during embryonic development. Neuron. 7:1991;717-727.
25. Durbec P.L., Larsson-Blomber L.B., Schuchardt A., Costantini F., Pachnis V. Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development. 122:1996;349-358.
26. Kapur R.P. Colonization of the murine hindgut by sacral crest-derived neural precursors: experimental support for an evolutionarily conserved model. Dev. Biol. 227:2000;146-155.
27. Burns A.J., Champeval D., Le Douarin N.M. Sacral neural crest cells colonise aganglionic hindgut in vivo but fail to compensate for lack of enteric ganglia. Dev. Biol. 219:2000;30-43.
28. Burns A.J., Douarin N.M. The sacral neural crest contributes neurons and glia to the post-umbilical gut: spatiotemporal analysis of the development of the enteric nervous system. Development. 125:1998;4335-4347.
29. Serbedzija G.N., Burgan S., Fraser S.E., Bronner-Fraser M. Vital dye labelling demonstrates a sacral neural crest contribution to the enteric nervous system of chick and mouse embryos. Development. 111:1991;857-866.
30. Pomeranz H.D., Sherman D.L., Smalheiser N.R., Tennyson V.M., Gershon M.D. Expression of a neurally related laminin binding protein by neural crest-derived cells that colonize the gut: relationship to the formation of enteric ganglia. J. Comp. Neurol. 13:1991;625-642.
31. Romeo G., Ronchetto P., Luo Y., Barone V., Seri M., Ceccherini I., Pasini B., Bocciardi R., Lerone M., Kaariainen H. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 367:1994;377-378.
32. Edery P., Lyonnet S., Mulligan L.M., Pelet A., Dow E., Abel L., Holder S., Nihoul-Fekete C., Ponder B.A., Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 367:1994;378-380.
33. Hofstra R.M., Wu Y., Stulp R.P., Elfferich P., Osinga J., Maas S.M., Siderius L., Brooks A.S., vd Ende J.J., Heydendael V.M., Severijnen R.S., Bax K.M., Meijers C., Buys C.H. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum. Mutat. 15:2000;418-429.
34. Chakravarti A., Lyonnet S. Hirschsprung disease. Scriver C., Beaudet A., Sly W., Valle D. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. 2001;6231-6255 McGraw Hill, New York. (pp. 931-942).
35. Bolk S., Pelet A., Hofstra R.M., Angrist M., Salomon R., Croaker D., Buys C.H., Lyonnet S., Chakravarti A. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc. Natl. Acad. Sci. USA. 97:2000;268-273.
36. Hofstra R.M., Landsvater R.M., Ceccherini I., Stulp R.P., Stelwagen T., Luo Y., Pasini B., Hoppener J.W., van Amstel H.K., Romeo G. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:1994;375-376.
37. Carlson K.M., Dou S., Chi D., Scavarda N., Toshima K., Jackson C.E., Wells S.A. Jr., Goodfellow P.J., Donis-Keller H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. USA. 91:1994;1579-1583.
38. Mulligan L.M., Eng C., Attie T., Lyonnet S., Marsh D.J., Hyland V.J., Robinson B.G., Frilling A., Verellen-Dumoulin C., Safar A. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum. Mol. Genet. 3:1994;2163-2167.
39. Mulligan L.M., Eng C., Healey C.S., Clayton D., Kwok J.B., Gardner E., Ponder M.A., Frilling A., Jackson C.E., Lehnert H. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nat. Genet. 6:1994;70-74.
40. Eng C., Smith D.P., Mulligan L.M., Nagai M.A., Healey C.S., Ponder M.A., Gardner E., Scheumann G.F., Jackson C.E., Tunnacliffe A. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 3:1994;237-241.
41. Seri M., Yin L., Barone V., Bolino A., Celli I., Bocciardi R., Pasini B., Ceccherini I., Lerone M., Kristoffersson U., Larsson L.T., Casasa J.M., Cass D.T., Abramowicz M.J., Vanderwinden J.M., Kravcenkiene I., Baric I., Silengo M., Martucciello G., Romeo G. Frequency of RET mutations in long- and short-segment Hirschsprung disease. Hum. Mutat. 9:1997;243-249.
42. Takahashi M., HIwashita T., Santoro M., Lyonnet S., Lenoir G.M., Billaud M. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function. Hum. Mutat. 13:1999;331-336.
43. Enomoto H., Araki T., Jackman A., Heuckeroth R.O., Snider W.D., Johnson E.M. Jr., Milbrandt J. GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron. 21:1998;317-324.
44. Cacalano G., Farinas I., Wang L.C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A.M., Reichardt L.F., Hynes M., Davies A., Rosenthal A. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron. 21:1998;53-62.
45. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 367:1994;380-383.
46. Moore M.W., Klein R.D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., Carver-Moore K., Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature. 382:1996;76-79.
47. Tomac A.C., Grinberg A., Huang S.P., Nosrat C., Wang Y., Borlongan C., Lin S.Z., Chiang Y.H., Olson L., Westphal H., Hoffer B.J. Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience. 95:2000;1011-1023.
48. Natarajan D., Grigoriou M., Marcos-Gutierrez C.V., Atkins C., Pachnis V. Multipotential progenitors of the mammalian enteric nervous system capable of colonising aganglionic bowel in organ culture. Dev. Suppl. 126:1999;157-168.
49. Puffenberger E.G., Hosoda K., Washington S.S., Nakao K., deWit D., Yanagisawa M., Chakravarti A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung disease. Cell. 79:1994;1257-1266.
50. Hofstra R.M., Osinga J., Tan-Sindhunata G., Wu Y., Kamsteeg E.J., Stulp R.P., van Ravenswaaij-Arts C., Majoor-Krakauer D., Angrist M., Chakravarti A., Meijers C., Buys C.H. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat. Genet. 12:1996;445-447.
51. Edery P., Attie T., Amiel J., Pelet A., Eng C., Hofstra R.M., Martelli H., Bidaud C., Munnich A., Lyonnet S. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat. Genet. 12:1996;442-444.
52. Attie T., Till M., Pelet A., Amiel J., Edery P., Bautrand L., Munnich A., Lyonnet S. Mutation of the endothelin-receptor B gene in Waardenberg-Hirschsprung disease. Hum. Molec. Genet. 4:1995;2407-2409.
53. Amiel J., Attie T., Jan D., Pelet A., Edery P., Bidaud C., Lacombe D., Tam P., Simeoni J., Flori E., Nihoul-Fekete C., Munnich A., Lyonnet S. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum. Mol. Genet. 5:1996;355-357.
54. Auricchio A., Casari G., Staiano A., Ballabio A. Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum. Mol. Genet. 5:1996;351-354.
55. Carrasquillo M.M., McCallion A.S., Puffenberger E.G., Kashuk C.S., Nouri N., Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat. Genet. 32:2002;237-244.
56. Hearn C.J., Murphy M., Newgreen D. GDNF and ET-3 differentially modulate the numbers of avian enteric neural crest cells and enteric neurons in vitro. Dev. Biol. 197:1998;93-105.
57. Wu J.J., Chen J.X., Rothman T.P., Gershon M.D. Inhibition of in vitro enteric neuronal development by endothelin-3: mediation by endothelin B receptors. Development. 126:1999;1161-1173.
58. Pingault V., Bondurand N., Kuhlbrodt K., Goerich D.E., Prehu M.O., Puliti A., Herbarth B., Hermans-Borgmeyer I., Legius E., Matthijs G., Amiel J., Lyonnet S., Ceccherini I., Romeo G., Smith J.C., Read A.P., Wegner M., Goossens M. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 18:1998;171-173.
59. Southard-Smith E.M., Angrist M., Ellison J.S., Agarwala R., Baxevanis A.D., Chakravarti A., Pavan W.J. The Sox10 (Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res. 9:1999;215-225.
60. Touraine R.L., Attie-Bitach T., Manceau E., Korsch E., Sarda P., Pingault V., Encha-Razavi F., Pelet A., Auge J., Nivelon-Chevallier A., Holschneider A.M., Munnes M., Doerfler W., Goossens M., Munnich A., Vekemans M., Lyonnet S. Neurological phenotype in Waardenburgh syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am. J. Hum. Genet. 66:2000;1496-14503.
61. Inoue K., Tanabe Y., Lupski J.R. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 46:1999;313-318.
62. Kapur R.P. Early death of neural crest cells is responsible for total enteric aganglionosis in Sox10Dom/sox10Dom mouse embryos. Pediatr. Dev. Pathol. 2:1999;559-569.
63. Southard-Smith E.M., Kos L., Pavan W.J. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18:1998;60-64.
64. Wakamatsu N., Yamada Y., Yamada K., Ono T., Nomura N., Taniguchi H., Kitoh H., Mutoh N., Yamanaka T., Mushiake K., Kato K., Sonta S., Nagaya M. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat. Genet. 27:2001;369-370.
65. Yamada K., Yamada Y., Nomura N., Miura K., Wakako R., Hayakawa C., Matsumoto A., Kumagai T., Yoshimura I., Miyazaki S., Kato K., Sonta S., Ono H., Yamanaka T., Nagaya M., Wakamatsu N. Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. Am. J. Hum. Genet. 69:2001;1178-1185.
66. prime-CACCT sequences in candidate target genes. J. Biol. Chem. 274:1999;20489-20498.
67. Gabriel S.B., Salomon R., Pelet A., Angrist M., Amiel J., Fornage M., Attie-Bitach T., Olson J.M., Hofstra R.M., Buys C.H., Steffann J., Munnich A., Lyonnet S., Chakravarti A. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat. Genet. 31:2002;89-93.
68. Brandi M.L., Gagel R.F., Angeli A., Bilezikian J.P., Beck-Peccoz P., Bordi C., Conte-Devolx B., Falchetti A., Gheri R.G., Libroia A., Lips C.J., Lombardi G., Mannelli M., Pacini F., Ponder B.A., Raue F., Skogseid B., Tamburrano G., Thakker R.V., Thompson N.W., Tomassetti P., Tonelli F., Wells S.A. Jr., Marx S.J. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metabol. 86:2001;5658-5671.
69. Gariepy C.E., Ohuchi T., Williams S.C., Richardson J.A., Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J. Clin. Invest. 105:2000;925-933.
70. Newby D.E., Strachan F.E., Webb D.J. Abnormal endothelin B receptor vasomotor responses in patients with Hirschsprung's disease. Qjm. 95:2002;159-163.
71. Sandgren K., Ekblad E., Larsson L.T. Survival of neurons and interstitial cells of Cajal after autotransplantation of myenteric ganglia from small intestine in the lethal spotted mouse. Pediatr. Surg. Int. 16:2000;272-276.
72. Bixby S., Kruger G.M., Mosher J.T., Joseph N.M., Morrison S.J. Cell-Intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron. 35:2002;643-656.
73. Kruger G.M., Mosher J.T., Bixby S., Joseph N.M., Iwashita T., Morrison S.J. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron. 35:2002;657-669.
74. Attie T., Pelet A., Edery P., Eng C., Mulligan L.M., Amiel J., Boutrand L., Beldjord C., Nihoul-Fekete C., Munnich A. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum. Mol. Genet. 4:1995;1381-1386.
75. Angrist M., Bolk S., Halushka M., Lapchak P.A., Chakravarti A. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat. Genet. 14:1996;341-344.
76. Ivanchuk S.M., Myers S.M., Eng C., Mulligan L.M. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Hum. Mol. Genet. 5:1996;2023-2026.
77. Chakravarti A. Endothelin receptor-mediated signaling in Hirschsprung disease. Hum. Molec. Genet. 5:1996;303-307.
78. Kusafuka T., Wang Y., Puri P. Novel mutations of the endothelin-b receptor gene in isolated patients with Hirschsprung's disease. Hum. Mol. Genet. 5:1996;347-349.
79. Verheij J.B., Kunze J., Osinga J., van Essen A.J., Hofstra R.M. ABCD syndrome is caused by a homozygous mutation in the EDNRB gene. Am. J. Med. Genet. 108:2002;223-225.
80. Boardman J.P., Syrris P., Holder S.E., Robertson N.J., Carter N., Lakhoo K. A novel mutation in the endothelin B receptor gene in a patient with Shah-Waardenburg syndrome and Down syndrome. J. Med. Genet. 38:2001;646-647.
81. Syrris P., Carter N.D., Patton M.A. Novel nonsense mutation of the endothelin-B receptor gene in a family with Waardenburg-Hirschsprung disease. Am. J. Med. Genet. 87:1999;69-71.
82. Bidaud C., Salomon R., Van Camp G., Pelet A., Attie T., Eng C., Bonduelle M., Amiel J., Nihoul-Fekete C., Willems P.J., Munnich A., Lyonnet S. Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur. J. Hum. Genet. 5:1997;247-251.
83. Kusafuka T., Wang Y., Puri P. Mutation analysis of the RET, the endothelin-B receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung's disease. J. Pediatr. Surg. 32:1997;501-504.
84. Pingault V., Bondurand N., Lemort N., Sancandi M., Ceccherini I., Hugot J.P. A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes? J. Med. Genet. 38:2001;205-209.
85. Hofstra R.M., Valdenaire O., Arch E., Osinga J., Kroes H., Loffler B.M., Hamosh A., Meijers C., Buys C.H. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am. J. Hum. Genet. 64:1999;304-308.
86. Sham M.H., Lui V.C., Chen B.L., Fu M., Tam P.K. Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome. J. Med. Genet. 38:2001;E30.